Longbow Capital

Longbow Capital is a UK-based venture capital firm that has been investing in the healthcare, life sciences, and well-being sectors since its founding in 2004. Headquartered in Norwich, the firm primarily focuses on unquoted UK companies with strong growth potential. Longbow Capital specializes in identifying investment opportunities that can deliver exceptional returns for its high-net-worth and professional clients. With a proven track record in both early and late-stage investments, Longbow is particularly interested in innovative healthcare technologies and life sciences, as well as companies that align with the growing well-being industry. The firm's portfolio includes standout companies such as Calon Cardio-Technology and Destiny Pharma, which have progressed through clinical trials and even to IPOs, reflecting Longbow’s ability to back transformative ventures. Longbow is also actively involved in fostering partnerships with innovation hubs like the Boots Centre for Innovation, a collaboration aimed at bringing cutting-edge health and well-being products to market. This initiative, based in Swansea, provides a pathway for early-stage companies and inventors to scale their products within established retail networks, ensuring greater market access. A key aspect of Longbow’s investment strategy is its focus on tax-efficient investment vehicles such as the Enterprise Investment Scheme (EIS) and Business Property Relief (BPR). These schemes offer UK investors significant tax relief on their investments, including income tax, capital gains tax, and inheritance tax benefits. This tax-efficient approach, combined with the firm's deep sector expertise, positions Longbow as a leading investor in the UK’s dynamic healthcare and life sciences landscape​.